Synergistic Influence of Rivaroxaban on Inflammation and Coagulation Biomarkers in Patients With CAD and PAD on Aspirin Therapy
Clinical trial NCT04059679 · UNKNOWN
Trial details
- NCT number
- NCT04059679
- Sponsor
- LifeBridge Health
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-30
- Primary completion
- 2021-03-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.